Drug Database
Back to search

Netherlands· NL-c891f66140ad

Foscan 1 mg/ml, oplossing voor injectie

A temoporfin product containing temoporfine, registered in Netherlands by Biolitec Pharma. The same ATC class is registered in 8 of our 19 countries.

ATC L01XD05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFoscan 1 mg/ml, oplossing voor inject…ATCL01XD05REGISTER NO.NL-c891f66140adPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about temoporfineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Temoporfin is registered in 8 of 19 countries.

Countries holding a registration under ATC L01XD05 (temoporfin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search temoporfin products by name

Temoporfin · ATC L01XD05

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TEMOPORFINE
Manufacturer
Biolitec Pharma
Country
Netherlands (NL)
ATC code
L01XD05
ATC class
Temoporfin
Defined daily dose
10.5 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/01/197

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Temoporfin in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All temoporfin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6ed90c02-781a-464e-87a8-46b616d7ae86
GET /v1/drugs/6ed90c02-781a-464e-87a8-46b616d7ae86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/foscan-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Temoporfin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73331",
  "excipients": [
    "ETHANOL",
    "PROPYLEENGLYCOL (E 1520)"
  ],
  "substances": [
    "TEMOPORFINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2007/10/15",
  "procedure_number": "EMEA/H/C/000318",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/01/197",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about temoporfin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console